121 related articles for article (PubMed ID: 12683417)
1. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
Ploss M; Berdel B; Heber R; Reuss FU
J Med Virol; 2003 Feb; 69(2):267-72. PubMed ID: 12683417
[TBL] [Abstract][Full Text] [Related]
2. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
Reuss FU; Berdel B; Ploss M; Heber R
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
[TBL] [Abstract][Full Text] [Related]
3. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants.
Reuss FU; Heber R; Ploss A; Berdel B
Virology; 2001 Dec; 291(1):91-100. PubMed ID: 11878879
[TBL] [Abstract][Full Text] [Related]
4. Replication of enhancer-deficient amphotropic murine leukemia virus in human fibrosarcoma but not in primary human fibroblasts.
Reuss FU; Berdel B; Heber R; Bantel-Schaal U
J Med Virol; 2002 Oct; 68(2):278-84. PubMed ID: 12210420
[TBL] [Abstract][Full Text] [Related]
5. Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblasts.
Reuss FU; Berdel B; Heber R; Ploss M
Gene Ther; 2002 Sep; 9(17):1183-8. PubMed ID: 12170382
[TBL] [Abstract][Full Text] [Related]
6. Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions.
Aagaard L; Rasmussen SV; Mikkelsen JG; Pedersen FS
Virology; 2004 Jan; 318(1):360-70. PubMed ID: 14972561
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
[TBL] [Abstract][Full Text] [Related]
8. Transcription start regions in the human genome are favored targets for MLV integration.
Wu X; Li Y; Crise B; Burgess SM
Science; 2003 Jun; 300(5626):1749-51. PubMed ID: 12805549
[TBL] [Abstract][Full Text] [Related]
9. Stable integration of a functional shRNA expression cassette into the murine leukemia virus genome.
Sliva K; Schnierle BS
Virology; 2006 Jul; 351(1):218-25. PubMed ID: 16631223
[TBL] [Abstract][Full Text] [Related]
10. Optimization of regulated LTR-mediated expression.
Lorens JB; Jang Y; Rossi AB; Payan DG; Bogenberger JM
Virology; 2000 Jun; 272(1):7-15. PubMed ID: 10873744
[TBL] [Abstract][Full Text] [Related]
11. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
Sliva K; Erlwein O; Bittner A; Schnierle BS
Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
[TBL] [Abstract][Full Text] [Related]
12. Phosphate depletion enhances the stability of the amphotropic murine leukemia virus receptor mRNA.
Chien ML; O'Neill E; Garcia JV
Virology; 1998 Jan; 240(1):109-17. PubMed ID: 9448695
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cis-regulatory elements in the 5' untranslated region of murine leukemia virus controlling protein expression.
Yamamoto N; Takase-Yoden S
Microbiol Immunol; 2009 Mar; 53(3):140-8. PubMed ID: 19302524
[TBL] [Abstract][Full Text] [Related]
14. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
[TBL] [Abstract][Full Text] [Related]
15. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
16. Transgene stability for three replication-competent murine leukemia virus vectors.
Duch M; Carrasco ML; Jespersen T; Hansen BD; Pedersen FS
Gene; 2004 Mar; 329():61-9. PubMed ID: 15033529
[TBL] [Abstract][Full Text] [Related]
17. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
Kim S; Park EJ; Yu SS; Kim S
J Virol Methods; 2004 Jun; 118(1):1-7. PubMed ID: 15158062
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
Mbisa JL; Nikolenko GN; Pathak VK
J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
[TBL] [Abstract][Full Text] [Related]
19. Unique three-repeat sequences containing FVa, LVb/C4, and CORE motifs in LTR-U3 of Friend murine leukemia virus clone A8 accelerate the induction of thymoma in rat.
Takase-Yoden S; Watanabe R
Virology; 2004 Aug; 326(1):29-40. PubMed ID: 15262492
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
